Radioactive Drug Research Committee
The Radioactive Drug Research Subcommittee is charged with institutional oversight for the human use applications of radioactive materials. This Subcommittee reports to the Pharmacy and Therapeutics Committee.
Membership: Consists of at least five individuals qualified in various disciplines pertinent to the field of nuclear medicine, including a physician recognized as a specialist in nuclear medicine who shall serve as Chair, a person qualified by training and experience to formulate radioactive drugs, and other persons with special competence in radiation safety and radiation dosimetry. Membership shall be drawn from representatives of the Clinical Staff and other faculty of the University of Virginia.
Meetings: The Radioactive Drug Research Subcommittee shall meet as necessary.
Duties and Responsibilities:
- Monitors the human use applications of non-FDA approved radioactive materials and ensures compliance with federal regulations
- Reviews and makes recommendations regarding the use of radionuclide tracer agents
- Reviews protocols submitted to the Human Investigation Committee that involve the use of radiation in any form which is not a standard of care
- Communicates findings to the University of Virginia Radiation Safety committee and the Medical Center Safety and Security Subcommittee
- Submits an annual report to the FDA
- Submits an annual report to the Clinical Staff Executive Committee via the Pharmacy and Therapeutics Committee
Note, members will be added as it is necessary for the subcommittee to be convened.
|Stuart Berr, PhD, Chair
||Biomedical Engineering and Radiology & Medical Imaging
|Allen Goode, MS, DABR
||Lead Medical Physicist, Radiology & Medical Engineering